Literature DB >> 31621984

Epidermal growth factor receptor-extracellular-regulated kinase blockade upregulates TRIM32 signaling cascade and promotes neurogenesis after spinal cord injury.

Weiwei Xue1,2, Yannan Zhao1, Zhifeng Xiao1, Xianming Wu1, Dezun Ma1,2, Jin Han1, Xing Li1, Xiaoyu Xue1,2, Ying Yang1,2, Yongxiang Fang3, Caixia Fan4, Sumei Liu1,2, Bai Xu1, Sufang Han1, Bing Chen1, Haipeng Zhang1,2, Yongheng Fan1,2, Weiyuan Liu2, Qun Dong5, Jianwu Dai1,4.   

Abstract

Nerve regeneration is blocked after spinal cord injury (SCI) by a complex myelin-associated inhibitory (MAI) microenvironment in the lesion site; however, the underlying mechanisms are not fully understood. During the process of neural stem cell (NSC) differentiation, pathway inhibitors were added to quantitatively assess the effects on neuronal differentiation. Immunoprecipitation and lentivirus-induced overexpression were used to examine effects in vitro. In vivo, animal experiments and lineage tracing methods were used to identify nascent neurogenesis after SCI. In vitro results indicated that myelin inhibited neuronal differentiation by activating the epidermal growth factor receptor (EGFR)-extracellular-regulated kinase (ERK) signaling cascade. Subsequently, we found that tripartite motif (TRIM) 32, a neuronal fate-determining factor, was inhibited. Moreover, inhibition of EGFR-ERK promoted TRIM32 expression and enhanced neuronal differentiation in the presence of myelin. We further demonstrated that ERK interacts with TRIM32 to regulate neuronal differentiation. In vivo results indicated that EGFR-ERK blockade increased TRIM32 expression and promoted neurogenesis in the injured area, thus enhancing functional recovery after SCI. Our results showed that EGFR-ERK blockade antagonized MAI of neuronal differentiation of NSCs through regulation of TRIM32 by ERK. Collectively, these findings may provide potential new targets for SCI repair. ©AlphaMed Press 2019.

Entities:  

Keywords:  EGFR; myelin; neural stem cell; neurogenesis; neuronal differentiation; spinal cord injury

Year:  2019        PMID: 31621984     DOI: 10.1002/stem.3097

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  7 in total

1.  Perlecan Improves Blood Spinal Cord Barrier Repair Through the Integrin β1/ROCK/MLC Pathway After Spinal Cord Injury.

Authors:  Changnan Xie; Yihan Wang; Jinfeng Wang; Yizhou Xu; Haining Liu; Jiasong Guo; Lixin Zhu
Journal:  Mol Neurobiol       Date:  2022-10-10       Impact factor: 5.682

Review 2.  Molecular approaches for spinal cord injury treatment.

Authors:  Fernanda Martins de Almeida; Suelen Adriani Marques; Anne Caroline Rodrigues Dos Santos; Caio Andrade Prins; Fellipe Soares Dos Santos Cardoso; Luiza Dos Santos Heringer; Henrique Rocha Mendonça; Ana Maria Blanco Martinez
Journal:  Neural Regen Res       Date:  2023-01       Impact factor: 6.058

3.  Ultrashort Wave Combined with Human Umbilical Cord Mesenchymal Stem Cell (HUC-MSC) Transplantation Inhibits NLRP3 Inflammasome and Improves Spinal Cord Injury via MK2/TTP Signalling Pathway.

Authors:  Li Na; Shuai Wang; Tongtong Liu; Lixin Zhang
Journal:  Biomed Res Int       Date:  2020-12-05       Impact factor: 3.411

4.  Deciphering Pharmacological Mechanism of Buyang Huanwu Decoction for Spinal Cord Injury by Network Pharmacology Approach.

Authors:  Zhencheng Xiong; Feng Yang; Wenhao Li; Xiangsheng Tang; Haoni Ma; Ping Yi
Journal:  Evid Based Complement Alternat Med       Date:  2021-04-22       Impact factor: 2.629

Review 5.  MAPK/ERK Pathway as a Central Regulator in Vertebrate Organ Regeneration.

Authors:  Xiaomin Wen; Lindi Jiao; Hong Tan
Journal:  Int J Mol Sci       Date:  2022-01-27       Impact factor: 5.923

6.  Upregulation of Apol8 by Epothilone D facilitates the neuronal relay of transplanted NSCs in spinal cord injury.

Authors:  Weiwei Xue; Haipeng Zhang; Yongheng Fan; Zhifeng Xiao; Yannan Zhao; Weiyuan Liu; Bai Xu; Yanyun Yin; Bing Chen; Jiayin Li; Yi Cui; Ya Shi; Jianwu Dai
Journal:  Stem Cell Res Ther       Date:  2021-05-26       Impact factor: 6.832

7.  Tripartite Motif Containing 52 Positively Regulates NF-κB Signaling by Promoting IκBα Ubiquitination in Lipopolysaccharide-Treated Microglial Cell Activation.

Authors:  Pei Zhang; Yimin Wu; Ruifeng Li; Huicheng Lv; Baolong Yu
Journal:  Med Sci Monit       Date:  2020-10-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.